Shaheen Lakhan, M.D.Medical Reviewer
Shaheen Lakhan, M.D., Ph.D., FAAN, is a physician-scientist and clinical development specialist. He is board-certified in both neurology and pain medicine with clinical training from the Cleveland Clinic and Massachusetts General Hospital. He has served as faculty in leading institutions (Harvard Medical School, Case Western Reserve University), founding neurology department chair and curricular dean (California University of Science and Medicine), institutional review board chair (Arrowhead Regional Medical Center), chief of pain management (Virginia Tech - Carilion Clinic), and medical director of clinical development (Sage Therapeutics). As vice president and head of research and development, Dr. Lakhan is now leading discovery research, preclinical to clinical development and operations, and regulatory affairs for a next-generation digital brain health therapeutics company (The Learning Corp).
In addition to exemplary clinical service as a neurologist and pain specialist, Dr. Lakhan has an extensive research, education, advocacy, and philanthropy portfolio. He has over 100 peer-reviewed journal publications, books, and book chapters. For founding the Global Neuroscience Initiative Foundation, he was bestowed the Harvard Medical School Dean's Community Service Award. He was also conferred the President's Call to Service Award for Lifetime Achievement by Pres. George W. Bush and The U.S. Congressional Award Gold Medal by Sen. Nancy Pelosi and Sen. Harry Reid. He has been appointed by California Gov. Brown and Virginia Gov. Northam to prestigious boards. Recognized by his peers, he was inducted as Fellow of the American Academy of Neurology, the Academy's highest designation.
Latest by Shaheen Lakhan, M.D.
Living like 'The Jetson's' isn’t too far off, thanks to technology that’s now being adapted to help those with multiple sclerosis to create "smart homes" equipped with gizmos that remote-control certain tasks.
Check your medicine cabinets—a new study found that anticholinergic drugs may make you more likely to develop dementia down the line.
Doing puzzles and taking supplements aren’t going to cut it. The good news? Warding off dementia is probably easier than you think.
People with vascular dementia may have sudden confusion, difficulty understanding a conversation, or speaking. Eileen discusses what happened when her father developed the condition.
Getting diagnosis of neuromyelitis optica spectrum disorder can be scary. Knowing what’s ahead can dispel some of that fear.
One of the scariest possible effects of neuromyelitis optica spectrum disorder is losing your sight. Here's what to know.
Sure, on paper NMOSD sounds super similar to MS. But, in the body, the two conditions look and feel very different.
When you’re diagnosed with neuromyelitis optica spectrum disorder, these specialists can help you get back to living.
We explain the rogue immune process that brings on the rare autoimmune disease neuromyelitis optica spectrum disorder.
Holding down a 9-to-5 while managing MS? Totally doable with these tips on making office life easier.